UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Quantitative assessment of minimal residual disease in acute myeloid leukemia carrying nucleophosmin (NPM1) gene mutations

Leukemia, 2006-06, Vol.20 (6), p.1103-1108

2006

Volltextzugriff (PDF)

Retinoic acid and arsenic trioxide sensitize acute promyelocytic leukemia cells to ER stress

Leukemia, 2018-02, Vol.32 (2), p.285-294

2018

Volltextzugriff (PDF)

Acute promyelocytic leukemia: a model for the role of molecular diagnosis and residual disease monitoring in directing treatment approach in acute myeloid leukemia

Leukemia, 2002-10, Vol.16 (10), p.1959-1973

2002

Volltextzugriff (PDF)

The E3 ubiquitin ligase WWP1 sustains the growth of acute myeloid leukaemia

Leukemia, 2018-04, Vol.32 (4), p.911-919

2018

Volltextzugriff (PDF)

Quantitative assessment of WT1 expression by real time quantitative PCR may be a useful tool for monitoring minimal residual disease in acute leukemia patients

Leukemia, 2002-10, Vol.16 (10), p.2115-2121

2002

Volltextzugriff (PDF)

Current management of newly diagnosed acute promyelocytic leukemia

Annals of oncology, 2016-08, Vol.27 (8), p.1474-1481

2016

Volltextzugriff (PDF)

Early and sensitive detection of PML-A216V mutation by droplet digital PCR in ATO-resistant acute promyelocytic leukemia

Leukemia, 2019-06, Vol.33 (6), p.1527-1530

2019

Volltextzugriff (PDF)

Arsenic trioxide-based therapy of relapsed acute promyelocytic leukemia: registry results from the European LeukemiaNet

Leukemia, 2015-05, Vol.29 (5), p.1084-1091

2015

Volltextzugriff (PDF)

A miRNA Signature in Human Cord Blood Stem and Progenitor Cells as Potential Biomarker of Specific Acute Myeloid Leukemia Subtypes

Journal of cellular physiology, 2015-08, Vol.230 (8), p.1770-1780

2015

Volltextzugriff (PDF)

Alterations of the FLT3 gene in acute promyelocytic leukemia: association with diagnostic characteristics and analysis of clinical outcome in patients treated with the italian AIDA protocol

Leukemia, 2002-11, Vol.16 (11), p.2185-2189

2002

Volltextzugriff (PDF)

Pre-transplant persistence of minimal residual disease does not contraindicate allogeneic stem cell transplantation for adult patients with acute myeloid leukemia

Bone marrow transplantation (Basingstoke), 2017-03, Vol.52 (3), p.473-475

2017

Volltextzugriff (PDF)

Interleukin-3 receptor in acute leukemia

Leukemia, 2004-02, Vol.18 (2), p.219-226

2004

Volltextzugriff (PDF)

Argonaute 2 sustains the gene expression program driving human monocytic differentiation of acute myeloid leukemia cells

Cell death & disease, 2013-11, Vol.4 (11), p.e926-e926

2013

Volltextzugriff (PDF)

Assessment of minimal residual disease (MRD) in CBFbeta/MYH11-positive acute myeloid leukemias by qualitative and quantitative RT-PCR amplification of fusion transcripts

Leukemia, 2002-06, Vol.16 (6), p.1176-1181

2002

Volltextzugriff (PDF)

PML–RARα kinetics and impact of FLT3–ITD mutations in newly diagnosed acute promyelocytic leukaemia treated with ATRA and ATO or ATRA and chemotherapy

Leukemia, 2016-10, Vol.30 (10), p.1987-1992

2016

Volltextzugriff (PDF)

Acute promyelocytic leukemia: a curable disease

Leukemia, 1998-12, Vol.12 (12), p.1866-1880

1998

Volltextzugriff (PDF)

Arsenic trioxide (ATO) and MEK1 inhibition synergize to induce apoptosis in acute promyelocytic leukemia cells

Leukemia, 2005-02, Vol.19 (2), p.234-244

2005

Volltextzugriff (PDF)

miRNA let-7c promotes granulocytic differentiation in acute myeloid leukemia

Oncogene, 2013-08, Vol.32 (31), p.3648-3654

2013

Volltextzugriff (PDF)

Extramedullary Involvement at Relapse in Acute Promyelocytic Leukemia Patients Treated or Not With All-Trans Retinoic Acid: A Report by the Gruppo Italiano Malattie Ematologiche dell’Adulto

Journal of clinical oncology, 2001-10, Vol.19 (20), p.4023-4028

2001

Volltextzugriff (PDF)

Expression Profiles of Acute Lymphoblastic and Myeloblastic Leukemias with ALL-1 Rearrangements

Proceedings of the National Academy of Sciences - PNAS, 2003-06, Vol.100 (13), p.7853-7858

2003

Volltextzugriff (PDF)

PML nuclear body disruption impairs DNA double-strand break sensing and repair in APL

Cell death & disease, 2016-07, Vol.7 (7), p.e2308-e2308

2016

Volltextzugriff (PDF)

Nucleophosmin/B26 regulates PTEN through interaction with HAUSP in acute myeloid leukemia

Leukemia, 2013-05, Vol.27 (5), p.1037-1043

2013

Volltextzugriff (PDF)

Incidence and significance of cryptic chromosome aberrations detected by fluorescence in situ hybridization in acute myeloid leukemia with normal karyotype

Leukemia, 2002-09, Vol.16 (9), p.1745-1751

2002

Volltextzugriff (PDF)

Infectious complications in patients with acute promyelocytic leukaemia treated with the AIDA regimen

Leukemia, 2003-05, Vol.17 (5), p.925-930

2003

Volltextzugriff (PDF)

Gemtuzumab ozogamicin (Mylotarg) as a single agent for molecularly relapsed acute promyelocytic leukemia

Blood, 2004-10, Vol.104 (7), p.1995-1999

2004

Volltextzugriff (PDF)

1 – 25 von 464

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(438)
Mit Volltextzugriff
(375)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(291)
Humans
(285)
Life Sciences & Biomedicine
(275)
Biological And Medical Sciences
(176)
Hematology
(175)
Medical Sciences
(165)
Male
(132)
Female
(128)
Hematologic And Hematopoietic Diseases
(127)
Adult
(125)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(119)
Oncology
(116)
Middle Aged
(114)
Aged
(76)
Adolescent
(75)
Leukemia, Promyelocytic, Acute - Genetics
(65)
Leukemia, Promyelocytic, Acute - Drug Therapy
(62)
Leukemia
(58)
Translocation, Genetic
(49)
Child
(41)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Quantitative assessment of minimal residual disease in acute myeloid leukemia carrying nucleophosmin (NPM1) gene mutations

Retinoic acid and arsenic trioxide sensitize acute promyelocytic leukemia cells to ER stress

Acute promyelocytic leukemia: a model for the role of molecular diagnosis and residual disease monitoring in directing treatment approach in acute myeloid leukemia

The E3 ubiquitin ligase WWP1 sustains the growth of acute myeloid leukaemia

Quantitative assessment of WT1 expression by real time quantitative PCR may be a useful tool for monitoring minimal residual disease in acute leukemia patients

Current management of newly diagnosed acute promyelocytic leukemia

Early and sensitive detection of PML-A216V mutation by droplet digital PCR in ATO-resistant acute promyelocytic leukemia

Arsenic trioxide-based therapy of relapsed acute promyelocytic leukemia: registry results from the European LeukemiaNet

A miRNA Signature in Human Cord Blood Stem and Progenitor Cells as Potential Biomarker of Specific Acute Myeloid Leukemia Subtypes

Alterations of the FLT3 gene in acute promyelocytic leukemia: association with diagnostic characteristics and analysis of clinical outcome in patients treated with the italian AIDA protocol

Pre-transplant persistence of minimal residual disease does not contraindicate allogeneic stem cell transplantation for adult patients with acute myeloid leukemia

Interleukin-3 receptor in acute leukemia

Argonaute 2 sustains the gene expression program driving human monocytic differentiation of acute myeloid leukemia cells

Assessment of minimal residual disease (MRD) in CBFbeta/MYH11-positive acute myeloid leukemias by qualitative and quantitative RT-PCR amplification of fusion transcripts

PML–RARα kinetics and impact of FLT3–ITD mutations in newly diagnosed acute promyelocytic leukaemia treated with ATRA and ATO or ATRA and chemotherapy

Acute promyelocytic leukemia: a curable disease

Arsenic trioxide (ATO) and MEK1 inhibition synergize to induce apoptosis in acute promyelocytic leukemia cells

miRNA let-7c promotes granulocytic differentiation in acute myeloid leukemia

Extramedullary Involvement at Relapse in Acute Promyelocytic Leukemia Patients Treated or Not With All-Trans Retinoic Acid: A Report by the Gruppo Italiano Malattie Ematologiche dell’Adulto

Expression Profiles of Acute Lymphoblastic and Myeloblastic Leukemias with ALL-1 Rearrangements

PML nuclear body disruption impairs DNA double-strand break sensing and repair in APL

Nucleophosmin/B26 regulates PTEN through interaction with HAUSP in acute myeloid leukemia

Incidence and significance of cryptic chromosome aberrations detected by fluorescence in situ hybridization in acute myeloid leukemia with normal karyotype

Infectious complications in patients with acute promyelocytic leukaemia treated with the AIDA regimen

Gemtuzumab ozogamicin (Mylotarg) as a single agent for molecularly relapsed acute promyelocytic leukemia

Suchergebnisse filtern